NASDAQ : APYX
-$0.03 (-0.77%)
NASDAQ
Charles D. Goodwin
Medical - Specialties
Healthcare
APYX
205
US
USD
3.08
5.80
4.79
3.30
0.00
$52.84M
2.91
12.68
-18.08
-0.21
-$0.27
-$11.21M
-16.40%
-15.58%
-90.62%
-14.55%
-17.34
-0.15
-0.15
$6.50
$7.00
$6.00
1/5
9 Analysts
-40.62%
1.53
3/9
$45.35M
$63.02M
$49.94M
-$3.13M
$171.36M
3.07
-70.14
5.80
-90.62%
-7.97%
-5.59%
-5.51%
150 days
| Name | Title |
|---|---|
| Matthew C. Hill | Chief Financial Officer, Treasurer & Secretary |
| Shawn D. Roman | Chief Operating Officer |
| Dolores Catania | Chief of Confidence |
| Charles D. Goodwin | President, Chief Executive Officer & Director |
| Moshe Citronowicz | Senior Vice President |
No votes yet today — be the first to share your view!
About Apyx Medical Corporation (NASDAQ:APYX) Stock
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company’s helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generat ... ors and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Apyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth Conference
2026-07-28 08:00:00
CLEARWATER, Fla., July 28, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced that management will participate in the Canaccord Genuity 46th Annual Growth Conference on Tuesday, August 11, 2026, in Boston, MA.
2026-07-23 08:00:00
CLEARWATER, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced that its financial results for the second quarter of fiscal year 2026 will be released after markets close on Thursday, August 6th.
2026-05-27 09:51:00
CLEARWATER, Fla., May 27, 2026 /PRNewswire/ -- Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical" or the "Company"), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), will return to Miami Swim Week with its Body by Apyx showcase, an immersive runway experience featuring real patient transformations.
2026-05-21 08:00:00
Published data demonstrates visible reduction in dimpling and progressive tissue remodeling through a single-session approach Published data demonstrates visible reduction in dimpling and progressive tissue remodeling through a single-session approach
2026-05-14 08:00:00
CLEARWATER, Fla., May 14, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced the publication of a new retrospective investigator-initiated study in Plastic and Reconstructive Surgery - Global Open 1.
2026-05-11 08:00:00
Addition of the power liposuction capability as a second advanced liposuction modality is expected to drive even greater market demand for AYON Addition of the power liposuction capability as a second advanced liposuction modality is expected to drive even greater market demand for AYON
Apyx Medical Corporation (APYX) Q1 2026 Earnings Call Transcript
2026-05-07 19:11:17
Apyx Medical Corporation (APYX) Q1 2026 Earnings Call Transcript
Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates
2026-05-07 09:51:05
Apyx Medical (APYX) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.1 per share a year ago.
Frequently Asked Questions
What is the current Apyx Medical Corporation (APYX) stock price?
Apyx Medical Corporation(NASDAQ:APYX) stock price is $3.86 in the last trading session. During the trading session, APYX stock reached the peak price of $5.08 while $1.59 was the lowest point it dropped to. The percentage change in APYX stock occurred in the recent session was --0.77% while the dollar amount for the price change in APYX stock was -$0.03.
APYX's industry and sector of operation?
The NASDAQ listed APYX is part of Medical - Specialties industry that operates in the broader Healthcare sector.
Who are the executives of APYX?
Matthew C. Hill
| Chief Financial Officer, Treasurer & Secretary
Shawn D. Roman
| Chief Operating Officer
Dolores Catania
| Chief of Confidence
Charles D. Goodwin
| President, Chief Executive Officer & Director
Moshe Citronowicz
| Senior Vice President
How many employees does APYX have?
Number of APYX employees currently stands at 205. APYX operates from 5115 Ulmerton Road, Clearwater, FL 33760-4004, US.
Link for APYX official website?
Official Website of APYX is: https://apyxmedical.com
How do I contact APYX?
APYX could be contacted at phone #727 384 2323 and can also be accessed through its website. APYX operates from 5115 Ulmerton Road, Clearwater, FL 33760-4004, US.
How many shares of APYX are traded daily?
The average number of APYX shares traded daily for last 3 months was 161.96K.
What is the market cap of APYX currently?
The market value of APYX currently stands at $162.55M with its latest stock price at $3.86